BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

783 related articles for article (PubMed ID: 29034591)

  • 1. Organ-On-A-Chip Platforms: A Convergence of Advanced Materials, Cells, and Microscale Technologies.
    Ahadian S; Civitarese R; Bannerman D; Mohammadi MH; Lu R; Wang E; Davenport-Huyer L; Lai B; Zhang B; Zhao Y; Mandla S; Korolj A; Radisic M
    Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 29034591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling Differentiation of Stem Cells for Developing Personalized Organ-on-Chip Platforms.
    Geraili A; Jafari P; Hassani MS; Araghi BH; Mohammadi MH; Ghafari AM; Tamrin SH; Modarres HP; Kolahchi AR; Ahadian S; Sanati-Nezhad A
    Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 28910516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Hydrogels in Organoids and Organs-on-a-Chip.
    Liu H; Wang Y; Cui K; Guo Y; Zhang X; Qin J
    Adv Mater; 2019 Dec; 31(50):e1902042. PubMed ID: 31282047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomimetic tissues on a chip for drug discovery.
    Ghaemmaghami AM; Hancock MJ; Harrington H; Kaji H; Khademhosseini A
    Drug Discov Today; 2012 Feb; 17(3-4):173-81. PubMed ID: 22094245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular human organ-on-a-chip platform for disease modeling, drug development, and personalized therapy.
    Khanna A; Oropeza BP; Huang NF
    J Biomed Mater Res A; 2024 Apr; 112(4):512-523. PubMed ID: 37668192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver organ-on-chip models for toxicity studies and risk assessment.
    Messelmani T; Morisseau L; Sakai Y; Legallais C; Le Goff A; Leclerc E; Jellali R
    Lab Chip; 2022 Jun; 22(13):2423-2450. PubMed ID: 35694831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Organ-on-a-Chip Materials and Devices.
    Nahak BK; Mishra A; Preetam S; Tiwari A
    ACS Appl Bio Mater; 2022 Aug; 5(8):3576-3607. PubMed ID: 35839513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human organotypic bioconstructs from organ-on-chip devices for human-predictive biological insights on drug candidates.
    Cavero I; Guillon JM; Holzgrefe HH
    Expert Opin Drug Saf; 2019 Aug; 18(8):651-677. PubMed ID: 31268355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of Biochip Technology: A Review from Lab-on-a-Chip to Organ-on-a-Chip.
    Azizipour N; Avazpour R; Rosenzweig DH; Sawan M; Ajji A
    Micromachines (Basel); 2020 Jun; 11(6):. PubMed ID: 32570945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in cardiac tissue engineering and heart-on-a-chip.
    Kieda J; Shakeri A; Landau S; Wang EY; Zhao Y; Lai BF; Okhovatian S; Wang Y; Jiang R; Radisic M
    J Biomed Mater Res A; 2024 Apr; 112(4):492-511. PubMed ID: 37909362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosynthetic, biomimetic, and self-assembled vascularized Organ-on-a-Chip systems.
    Fritschen A; Blaeser A
    Biomaterials; 2021 Jan; 268():120556. PubMed ID: 33310539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next generation human skin constructs as advanced tools for drug development.
    Abaci HE; Guo Z; Doucet Y; Jacków J; Christiano A
    Exp Biol Med (Maywood); 2017 Nov; 242(17):1657-1668. PubMed ID: 28592171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ-on-a-chip technologies that can transform ophthalmic drug discovery and disease modeling.
    Haderspeck JC; Chuchuy J; Kustermann S; Liebau S; Loskill P
    Expert Opin Drug Discov; 2019 Jan; 14(1):47-57. PubMed ID: 30526132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ-on-Chip platforms to study tumor evolution and chemosensitivity.
    Dsouza VL; Kuthethur R; Kabekkodu SP; Chakrabarty S
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188717. PubMed ID: 35304293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of natural biomaterials for micro-tissue and organ-on-chip models.
    Cecen B; Bal-Ozturk A; Yasayan G; Alarcin E; Kocak P; Tutar R; Kozaci LD; Shin SR; Miri AK
    J Biomed Mater Res A; 2022 May; 110(5):1147-1165. PubMed ID: 35102687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organs-on-a-chip for drug discovery.
    Selimović S; Dokmeci MR; Khademhosseini A
    Curr Opin Pharmacol; 2013 Oct; 13(5):829-33. PubMed ID: 23850526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering Tissue Barrier Models on Hydrogel Microfluidic Platforms.
    Vera D; García-Díaz M; Torras N; Álvarez M; Villa R; Martinez E
    ACS Appl Mater Interfaces; 2021 Mar; 13(12):13920-13933. PubMed ID: 33739812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From cardiac tissue engineering to heart-on-a-chip: beating challenges.
    Zhang YS; Aleman J; Arneri A; Bersini S; Piraino F; Shin SR; Dokmeci MR; Khademhosseini A
    Biomed Mater; 2015 Jun; 10(3):034006. PubMed ID: 26065674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lab-on-a-Chip Platforms as Tools for Drug Screening in Neuropathologies Associated with Blood-Brain Barrier Alterations.
    Staicu CE; Jipa F; Axente E; Radu M; Radu BM; Sima F
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34205550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakthroughs and Applications of Organ-on-a-Chip Technology.
    Koyilot MC; Natarajan P; Hunt CR; Sivarajkumar S; Roy R; Joglekar S; Pandita S; Tong CW; Marakkar S; Subramanian L; Yadav SS; Cherian AV; Pandita TK; Shameer K; Yadav KK
    Cells; 2022 Jun; 11(11):. PubMed ID: 35681523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.